DePuy Synthes’s Inhance Shoulder System Gains New Clearance

DePuy Synthes’s Inhance shoulder system has received an expanded 510(k) clearance from the FDA for use in reverse total shoulder arthroplasty procedures. The agency previously cleared the system for use anatomic shoulder arthroplasty.

Reverse total shoulder arthroplasty involves replacing the rounded head of the upper arm bone and part of the socket of the shoulder blade with implants. Anatomic total shoulder arthroplasty replaces damaged sections of the humerus bones and cartilage.

The system, which features a range of sizes for different patient anatomies, includes 3D laser-printed baseplates and a Vitamin E polyethylene coating for oxidative stability, the company said.

Warsaw, Ind.-based DePuy Synthes is the orthopedics subsidiary of Johnson & Johnson MedTech.